Patients With Relapse Remitting Multiple Sclerosis (RRMS): Candidates for MS Therapy Change

NCT01317004 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsing Remitting Multiple Sclerosis

Interventions

DRUG: Fingolimod
DRUG: Standard MS DMT

Sponsor

Novartis Pharmaceuticals